AbbVie reports data from trial of hidradenitis suppurativa drug

Submitted by admin on January 9, 2024 - 10:01pm

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

US-based pharmaceutical company AbbVie has reported positive data from its Phase II clinical trial of the investigational drug lutikizumab (ABT-981).

Search form